Assess Safety & Reactogenicity of GSK Biologicals' Hib Vaccine Co-administered With or Without Chinese DTPw Vaccine

Clinical trial NCT00158795 · COMPLETED

Trial details

NCT number: NCT00158795
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Haemophilus Influenzae Type b Disease

Start date: 2005-01-01
Primary completion: 2005-07-01
Enrollment: 454

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.